Celgene and Natco settle Revlimid dispute

05-01-2016

Celgene and Natco settle Revlimid dispute

Photo: Courtesy of Celgene (https://www.celgene.com/media-library/celgene-logo-with-tagline-no-background/)

Biopharmaceutical company Celgene and India-based rival Natco Pharma have settled a lawsuit centring on the alleged infringement of a number patents covering the Revlimid (lenalidomide) drug.


Celgene; Natco Pharma; Revlimid; cancer

LSIPR